97 related articles for article (PubMed ID: 7596767)
1. [Radiation therapy for brain metastases from lung carcinoma: the second prospective randomized trial].
Chatani M; Matayoshi Y; Masaki N; Inoue T
Nihon Igaku Hoshasen Gakkai Zasshi; 1994 Dec; 54(14):1380-7. PubMed ID: 7596767
[TBL] [Abstract][Full Text] [Related]
2. Radiation therapy for brain metastases from lung carcinoma. Prospective randomized trial according to the level of lactate dehydrogenase.
Chatani M; Matayoshi Y; Masaki N; Inoue T
Strahlenther Onkol; 1994 Mar; 170(3):155-61. PubMed ID: 8160096
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors in patients with brain metastases from lung carcinoma: preliminary result of the second trial.
Chatani M; Teshima T; Hata K; Inoue T
Strahlenther Onkol; 1990 Aug; 166(8):562-7. PubMed ID: 2168584
[TBL] [Abstract][Full Text] [Related]
4. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
5. [Prognostic factors in patients with brain metastases from lung carcinoma].
Chatani M; Teshima T; Inoue T
Gan No Rinsho; 1989 Oct; 35(13):1596-601. PubMed ID: 2585731
[TBL] [Abstract][Full Text] [Related]
6. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
Yue X; Zang QC
Ai Zheng; 2004 Dec; 23(12):1671-6. PubMed ID: 15601558
[TBL] [Abstract][Full Text] [Related]
7. Toxicity and outcome results of RTOG 9311: a phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma.
Bradley J; Graham MV; Winter K; Purdy JA; Komaki R; Roa WH; Ryu JK; Bosch W; Emami B
Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):318-28. PubMed ID: 15667949
[TBL] [Abstract][Full Text] [Related]
8. Prognostic factors in patients with brain metastases from lung carcinoma.
Chatani M; Teshima T; Hata K; Inoue T
Strahlenther Onkol; 1986 Mar; 162(3):157-61. PubMed ID: 3515602
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy of permanent interstitial implantation of 125I seeds for solitary brain metastasis from non-small cell lung carcinoma].
Wang ZM; Wu J; Wang GC; Ren JL; Kjelle D
Ai Zheng; 2002 Oct; 21(10):1145-8. PubMed ID: 12508663
[TBL] [Abstract][Full Text] [Related]
10. Cost-utility analysis of short- versus long-course palliative radiotherapy in patients with non-small-cell lung cancer.
van den Hout WB; Kramer GW; Noordijk EM; Leer JW
J Natl Cancer Inst; 2006 Dec; 98(24):1786-94. PubMed ID: 17179480
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic radiosurgery plus whole-brain radiotherapy for treatment of multiple metastases from non-small cell lung cancer.
Minniti G; Salvati M; Muni R; Lanzetta G; Osti MF; Clarke E; Costa A; Bozzao A; Trasimeni G; Enrici RM
Anticancer Res; 2010 Jul; 30(7):3055-61. PubMed ID: 20683055
[TBL] [Abstract][Full Text] [Related]
12. Cisplatin/etoposide chemotherapy combined with twice daily thoracic radiotherapy for limited small-cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Wang LJ; Qian H; Fu XL; Yang H; Wu KL; Zhao S
Int J Radiat Oncol Biol Phys; 2005 Jan; 61(1):70-5. PubMed ID: 15629596
[TBL] [Abstract][Full Text] [Related]
13. Treatment of brain metastases from primary lung cancer.
Ryan GF; Ball DL; Smith JG
Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):273-8. PubMed ID: 7836080
[TBL] [Abstract][Full Text] [Related]
14. Two radiation regimens and prognostic factors for brain metastases in nonsmall cell lung cancer patients.
Rades D; Schild SE; Lohynska R; Veninga T; Stalpers LJ; Dunst J
Cancer; 2007 Sep; 110(5):1077-82. PubMed ID: 17614294
[TBL] [Abstract][Full Text] [Related]
15. Escalated hyperfractionated accelerated radiation therapy for locally advanced non-small cell lung cancer: a clinical phase II trial.
Chen GY; Jiang GL; Qian H; Wang LJ; Yang HJ; Fu XL; Wu KL; Zang Z; Zhao S
Radiother Oncol; 2004 May; 71(2):157-62. PubMed ID: 15110448
[TBL] [Abstract][Full Text] [Related]
16. Hypofractionated palliative radiotherapy (17 Gy per two fractions) in advanced non-small-cell lung carcinoma is comparable to standard fractionation for symptom control and survival: a national phase III trial.
Sundstrøm S; Bremnes R; Aasebø U; Aamdal S; Hatlevoll R; Brunsvig P; Johannessen DC; Klepp O; Fayers PM; Kaasa S
J Clin Oncol; 2004 Mar; 22(5):801-10. PubMed ID: 14990635
[TBL] [Abstract][Full Text] [Related]
17. The use of recursive partitioning analysis grouping in patients with brain metastases from non-small-cell lung cancer.
Gülbaş H; Erkal HS; Serin M
Jpn J Clin Oncol; 2006 Apr; 36(4):193-6. PubMed ID: 16611661
[TBL] [Abstract][Full Text] [Related]
18. [Whole brain irradiation for non-small-cell lung cancer with brain metastasis].
Shi AH; Zhu GY; Yu R; Ma HM; Liu CQ; Su X; Sun Y; Cai Y; Xu XN; Zhang SW; Xu B
Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):545-8. PubMed ID: 18069640
[TBL] [Abstract][Full Text] [Related]
19. [Whole-brain radiotherapy combined with COAPC regimen in patients with non-small cell lung cancer].
Chen LK; Xu GC; Liu GZ; Liang Y; Liu JL; Zhou XM
Ai Zheng; 2003 Apr; 22(4):407-10. PubMed ID: 12704000
[TBL] [Abstract][Full Text] [Related]
20. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]